相关实验视频
Updated: Jul 9, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
亚临床初级阿尔多斯特罗尼斯和心血管健康:基于人口的队列研究
Gregory L Hundemer1,2, Mohsen Agharazii3, François Madore4
1Department of Medicine, Division of Nephrology, University of Ottawa, Ontario, Canada (G.L.H., M.M.S., S.H., M.R.).
Circulation
|November 30, 2023
概括
亚临床原发性阿尔多斯特,以高的阿尔多斯特与的比率来表示,与较差的心血管健康有关. 这包括增加动脉硬,心脏重塑和患高血压的风险.
科学领域:
- 内分泌学
- 心脏病学
- 高血压研究
背景情况:
- 主要的阿尔多斯特是高血压和心血管疾病的常见原因.
- 亚临床形式是常见的,但它们对心血管的影响尚不清楚.
研究的目的:
- 调查亚临床原发性阿尔多斯特和心血管健康标志物之间的关联.
- 分析阿尔多与因比率与动脉硬,心脏重塑和发生性高血压之间的关系.
主要方法:
- 在CARTaGENE队列中对1284名年龄在40至69岁的成年人进行前性研究.
- 评估的阿尔多素,素和阿尔多素与素的比率.
- 测量中心血压,脉冲波速率,心脏核磁共振和发生高血压.
主要成果:
- 较高的阿尔多与蛋白比率与动脉硬度增加相关 (中心血压,脉冲波速率).
- 增加的比率与不良的心脏重塑有关 (左心房体积,左心房质量,左心房重塑指数).
- 观察到左心室缩和发生性高血压的可能性更高.
结论:
- 亚临床原发性阿尔多斯特症会对心血管健康产生负面影响.
- 生物化学标志物与动脉硬,心脏重塑和高血压风险有关.
- 这些结果与手臂血压无关.
相关概念视频
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Action of β1 Blockers
453
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
453
Psychoneuroimmunology: Cardiovascular Disease
31
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
31
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436

